Coastal Bridge Advisors, LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
Coastal Bridge Advisors, LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,289,705
-36.2%
406,8470.0%0.35%
-30.2%
Q2 2023$2,022,030
+0.6%
406,8470.0%0.50%
-2.4%
Q1 2023$2,009,824
-21.5%
406,8470.0%0.51%
-30.0%
Q4 2022$2,559,068
-40.7%
406,847
+1.9%
0.73%
-37.4%
Q3 2022$4,314,000
-5.8%
399,429
-0.6%
1.16%
-17.7%
Q2 2022$4,582,000
+25.1%
401,9290.0%1.41%
+67.3%
Q1 2022$3,662,000
-18.7%
401,929
+33.1%
0.84%
-10.1%
Q4 2021$4,505,000
-41.8%
301,929
+0.2%
0.94%
-47.6%
Q3 2021$7,742,000
-2.1%
301,240
-0.7%
1.79%
+10.4%
Q2 2021$7,908,000
-26.1%
303,2400.0%1.62%
-17.3%
Q1 2021$10,704,000
+9.9%
303,240
-21.4%
1.96%
+1.4%
Q4 2020$9,738,000
-42.5%
385,824
-14.1%
1.93%
-62.5%
Q3 2020$16,935,000
-14.6%
449,096
-3.0%
5.16%
-18.4%
Q2 2020$19,831,000
+52.2%
463,117
-30.9%
6.33%
+32.3%
Q1 2020$13,033,000
-26.1%
670,422
-1.2%
4.78%
+4.5%
Q4 2019$17,636,000
-21.5%
678,839
-17.7%
4.58%
-40.4%
Q3 2019$22,475,000
-27.6%
824,617
-28.6%
7.68%
-16.4%
Q2 2019$31,031,000
+599.2%
1,155,717
+652.8%
9.18%
+492.5%
Q1 2019$4,438,000
-8.9%
153,518
-15.2%
1.55%
-19.5%
Q4 2018$4,874,000181,0001.92%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders